Discovery of novel regulators of aldehyde dehydrogenase isoenzymes

Chemico-Biological Interactions

Volumn 191, Issue 1-3, 2011, Pages 153-158

  Parajuli, Bibek ^a   Kimble Hill, Ann C ^a   Khanna, May ^a   Ivanova, Yvelina ^a   Meroueh, Samy ^a   Hurley, Thomas D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aldehyde dehydrogenase; Computational docking; High throughput screening

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1A1; ALDEHYDE DEHYDROGENASE ISOENZYME 2; ALDEHYDE DEHYDROGENASE ISOENZYME 3A1; UNCLASSIFIED DRUG;

BINDING SITE; CATALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; HIGH THROUGHPUT SCREENING; HUMAN; HYDROLYSIS; IN VITRO STUDY; MOLECULAR DOCKING; PROTEIN EXPRESSION;

ALDEHYDE DEHYDROGENASE; DRUG DISCOVERY; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; ISOENZYMES; KINETICS;

EID: 79957579268     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2011.02.018     Document Type: Conference Paper

References (29)

1. R. Lindahl, Aldehyde dehydrogenases and their role in carcinogenesis, Crit. Rev. Biochem. Mol. Biol. 27 (1992) 283-335.
2. S.A. Marchetti, C. Brocker, D. Stagos, V. Vasiliou, Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily, Expert Opin. Drug Metab. Toxicol. 4 (2008) 697-720. (Pubitemid 352003194)
3. W. Black, V. Vasiliou, The aldehyde dehydrogenase gene superfamily resource center, Hum. Genomics 4 (2009) 136-142.
4. T.D. Hurley, H.J. Edenberg, T.-K. Li, The pharmacogenomics of alcoholism, in: J. Licinio, M.-L. Wong (Eds.), Pharmacogenomics: The Search for Individualized Therapeutics, Wiley-VCH, Weinheim, 2002, pp. 417-442.
5. C.H. Chen, G.R. Budas, E.N. Churchill, M.H. Disatnik, T.D. Hurley, D. Mochly-Rosen, Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart, Science 321 (2008) 1493-1495.
6. Z. Chen, J. Zhang, J.S. Stamler, Identification of the enzymatic mechanism of nitroglycerin bioactivation, Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8306-8311. (Pubitemid 34651048)
7. Z. Chen, M.W. Foster, J. Zhang, L. Mao, H.A. Rockman, T. Kawamoto, K. Kitagawa, K.I. Nakayama, D.T. Hess, J.S. Stamler, An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation, Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 12159-12164. (Pubitemid 41291145)
8. A. Kollau, A. Hofer, M. Russwurm, D. Koesling, W.M. Keung, K. Schmidt, F. Brunner, B. Mayer, Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide, Biochem. J. 385 (2005) 769-777. (Pubitemid 40208838)
9. L. Yao, P. Fan, M. Arolfo, Z. Jiang, M.F. Olive, J. Zablocki, H.-L. Sun, N. Chu, J. Lee, H.-Y. Kim, K. Leung, J. Shryock, B. Blackburn, I. Diamond, Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis, Nat. Med. 16 (2010) 1024-1028.
10. K. Niederreither, V. Subbarayan, P. Dollé, P. Chambon, Embryonic retinoic acid synthesis is essential for early mouse post-implantation development, Nat. Genet. 21 (1999) 444-448.
11. V. Dupé, N. Matt, J.M. Garnier, P. Chambon, M. Mark, N.B. Ghyselinck, A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment, Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 14036-14041. (Pubitemid 37499186)
12. C. Ginester, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C.G. Kleer, D. Liu, A. Schott, D. Hayes, D. Birnbaum, M.S. Wicha, G. Dontu, ALDH1 is amarker of normal and malignant humanmammary stem cells and a predictor of poor clinical outcome, Cell Stem Cell 1 (2007) 555-567. (Pubitemid 350056407)
13. F. Jiang, Q. Qiu, A. Khanna, N.W. Todd, J. Deepak, L. Xing, H. Wang, Z. Liu, Y. Su, S.A. Stass, R.L. Katz, Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer, Mol. Cancer Res. 7 (2009) 330-338.
14. L. Sreerama, N.E. Sladek, Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants. Rational individualization of cancer chemotherapeutic regimens, Cancer Chemother. Pharmacol. 47 (2001) 255-262.
15. A. Pappa, C. Chen, Y. Koutalos, A.J. Townsend, V. Vasiliou, ALDH3A1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage, Free Radic. Biol. Med. 34 (2003) 1178-1189. (Pubitemid 36426933)
16. J.S. Moreb, D. Mohuczy, B. Ostmark, J.R. Zucali, RNAi-mediated knockdown of aldehyde dehydrogenase class 1A1 and class 3A1 is specific and reveals that each contributes equally to the resistance against 4- hydroperoxycyclophosphamide, Cancer Chemother. Pharmacol. 59 (2007) 127-136.
17. K.K. Ho, A. Mukhopadhyay, Y.F. Li, S. Mukhopadhyay, H. Weiner, A point mutation produced in a class 3 aldehyde dehydrogenase with increased protective ability against the killing effect of cyclophosphamide, Biochem. Pharmacol. 76 (2008) 690-696.
18. C.G. Steinmetz, X. Peiguang, H. Weiner, T.D. Hurley, Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion, Structure 5 (1997) 701-711. (Pubitemid 27236268)
19. S.A. Moore, H.M. Baker, T.J. Blythe, K.E. Kitson, T.M. Kitson, E.N. Baker, Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases, Structure 6 (1998) 1541-1551.
20. Z.-J. Liu, Y.-J. Sun, J. Rose, Y.-J. Chung, C.-D. Hsiao, W.-R. Chang, I. Kuo, J. Perozich, R. Lindahl, J. Hempel, B.-C. Wang, The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold, Nat. Struct. Biol. 4 (1997) 317-326. (Pubitemid 27157205)
21. W.M. Keung, A.A. Klyosov, B.L. Vallee, Daidzin inhibits mitochondrial aldehyde dehydrogenase and suppresses ethanol intake of Syrian golden hamsters, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 1675-1679. (Pubitemid 27113894)
22. M.P. Arolfo, D.H. Overstreet, L. Yao, P. Fan, A.J. Lawrence, G. Tao, W.M. Keung, B.L. Vallee, M.F. Olive, J.T. Gass, E. Rubin, H. Anni, C.W. Hodge, J. Besheer, J. Zablocki, K. Leung, B.K. Blackburn, L.G. Lange, I. Diamond, Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor, Alcohol Clin. Exp. Res. 33 (2009) 1935-1944.
23. S. Perez-Miller, H. Younus, R. Vanam, C.H. Chen, D. Mochly-Rosen, T.D. Hurley, Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant, Nat. Struct. Mol. Biol. 17 (2010) 159-164.
24. P.K. Hammen, A. Allali-Hassani, K. Hallenga, T.D. Hurley, H. Weiner, Multiple conformations of NAD+ and NADH when bound to human cytosolic and mitochondrial aldehyde dehydrogenase, Biochemistry 41 (2002) 7156-7168. (Pubitemid 34575689)
25. S. Perez-Miller, T.D. Hurley, Coenzyme isomerization is integral to catalysis in aldehyde dehydrogenase, Biochemistry 42 (2003) 7100-7109. (Pubitemid 36712194)
26. J.M. Word, S.C. Lovell, J.S. Richardson, D.C. Richardson, Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation, J. Mol. Biol. 285 (1999) 1735-1747.
27. M.F. Sanner, Python: a programming language for software integration and development, J. Mol. Graph. Model. 17 (1999) 57-61. (Pubitemid 30029318)
28. J.J. Irwin, B.K. Shoichet, ZINC - a free database of commercially available compounds for virtual screening, J. Chem. Inf. Model. 45 (2005) 177-182.
29. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, A.J. Olson, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function, J. Comput. Chem. 19 (1998) 1639-1662.